The cells were cultured in DMEM-F12 (HyClone) supplemented with 10% FBS and 1% penicillin/streptomycin at 37 C in a humidified atmosphere of 5% CO 2
In the event DSIP does ultimately undergo clinical development, intranasal administration can ensure a higher degree of patient compliance by eliminating side effects and discomfort commonly associated with peptide injections
References Banhegyi G, Lusini L, Puskas F, Rossi R, Fulceri R, Braun L, Mile V, di Simplicio P, Mandl J, Benedetti A (1999) Preferential transport of glutathione versus glutathione disulfide in rat liver microsomal vesicles
These effects are not well-established in controlled human trials and should be considered speculative at this stage
Researchers running GHK-Cu alongside BPC-157 or TB-500 will recognize this as the GLOW blend protocol structure, which is well-documented and generally considered low risk by those familiar with the research literature
I would recommend this service and recommend the Glow drip